Regulations.gov document
Letter from BioNeutra North America Inc to FDA CFSAN
Other · FDA-2016-P-4275 · posted Aug 14, 2017
Key facts
| Document ID | FDA-2016-P-4275-0056 |
|---|---|
| Title | Letter from BioNeutra North America Inc to FDA CFSAN |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2016-P-4275 |
| Posted | Aug 14, 2017 |
| Comment period opens | Aug 14, 2017 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: